A Prospective Study of Surgical Treatment Strategies for Chordoma
Not Applicable
Recruiting
- Conditions
- Chordoma of SpineSurgery
- Interventions
- Procedure: Resection surgery
- Registration Number
- NCT05707767
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Brief Summary
Chordoma is a rare but locally invasive cancer that arises from the embryonic notochord. Total resection is challenging in mobile spine because of the complex anatomy and bone invasion.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Between the ages of 18 and 70 ys,
- With a diagnosis of chordoma confirmed by pathology,
- Undergone surgical treatment in our hospital,
- Available for clinical follow-up and agree to long-term clinical follow-up and sign informed consent.
Exclusion Criteria
- Suffer from other tumors,
- Suffer from cardiovascular disease, cerebrovascular disease, or immune system disease.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Chordoma Patients Resection surgery Chordoma Patients
- Primary Outcome Measures
Name Time Method Excision Extension 1 week after surgery. Clinical and radiographic assessments of excision extension of tumor.
- Secondary Outcome Measures
Name Time Method ORR (Objective Response Rate) 2 years Objective Response Rate of patient underwent surgery.
DFS (Disease Free Survival) 2 years Disease Free Survival of patient underwent surgery.
PFS (Progression-Free Survival) 2 years Progression-Free Survival of patient underwent surgery.
OS (Overall Survival) 2 years Overall Survival of patient underwent surgery.
Trial Locations
- Locations (1)
Xuanwu Hospital, Capital Medical University
🇨🇳Beijing, China